Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Biopolymers. 2011;96(5):688–693. doi: 10.1002/bip.21607

FIGURE 3. Bioconjugate stability in the presence of serum.

FIGURE 3

NMEGylated therapeutics were incubated in human plasma at 37 °C and sampled at certain time points, followed by RP-HPLC analysis. The amount of remaining peptide or peptide-peptoid conjugate at each time point was quantified against an enzyme-stable internal organic standard (benzyl alcohol).